Tenecteplase is equivalent to placebo between 4.5 and 24 hours after stroke onset
1. In this randomized controlled trial, tenecteplase administered at 4.5 to 24 hours after stroke onset to patients with an ...
1. In this randomized controlled trial, tenecteplase administered at 4.5 to 24 hours after stroke onset to patients with an ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
1. The 90-day modified Ranking Scale score was comparable for patients in intravenous thrombolysis plus endovascular treatment versus endovascular treatment ...
1. A similar proportion of patients in the alteplase group reported a modified Rankin Scale score of 0-1 compared to ...
1. IV tenecteplase was non-inferior to IV alteplase for treatment of acute ischemic stroke regarding the primary outcome of a ...
1. Fewer patients in the direct thrombectomy achieved functional independence at 90 days compared to the bridging therapy group. 2. ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.